Experimentally induced nasal hypersecretion does not reduce the efficacy of intranasal levocabastine

Keyphrases

• Intranasal 100%
• Hypersecretion 100%
• Nasal 100%
• Levocetirizine 100%
• Antihistamines 40%
• Allergic Rhinitis 40%
• Placebo 20%
• Onset of Action 20%
• Acute Episodes 20%
• Rhinitis 20%
• Nasal Cavity 20%
• Histamine 20%
• Symptom Response 20%
• Methacholine 20%
• Effect Parameter 20%
• Sneezing 20%
• Rhinorrhea 20%
• Histamine H1 Receptor 20%
• Methacholine Challenge 20%
• H1 Antagonists 20%
• Histamine Challenge 20%
• H1-antihistamines 20%
• Intranasal Treatment 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Levocabastine 100%
• Histamine 66%
• Symptom 66%
• Allergic Rhinitis 66%
• Antihistaminic Agent 66%
• Methacholine 66%
• Histamine H1 Receptor Antagonist 66%
• Placebo 33%
• Sodium Chloride 33%
• Rhinitis 33%
• Rhinorrhea 33%
• Histamine H1 Receptor 33%

Immunology and Microbiology

• Histamine 100%
• Levocabastine 100%
• Allergic Rhinitis 66%
• Histamine H1 Receptor Antagonist 66%
• Secretion (Process) 33%
• Rhinitis 33%
• Nose 33%
• Sneezing 33%